The future of contraception is making itself heard.
Choice is being mentioned in conversations about medical innovation, women’s rights, and technology that truly makes a difference.
Peter and Leonie visited Boston – THE medtech capital of the USA to join the RVO innovation mission for Women’s Health. During the 3 day event and the 2 day innovation mission we learned a lot about investors, other companies in the FemTech space and about the opportunities within the USA. Leonie presented Choice during […]
We are super excited to announce that the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will support Choice in the preclinical testing of the device. Soon we will start with the finalization of the protocol & tests are expected to start end of this year. NIH employs five broad decision […]
Leonie van de Kamer: “I am very proud to be part of this 6th batch of the Techleap Pole Position program with Choice – Female Proconception ! Last Tuesday was the wrap up of an intense 3-month period where Peter Van De Graaf, Joerg Stroetzel and I learned what it takes to get from a […]
Milestone alert! Today we kicked off our First in Women studies at the Maxima Medical Center Eindhoven. Our KOLs Marlies Bongers Peggy Geomini and Bas Veersema introduced the smallest endoscope in the world (1,1mm – developed by us!) in the tuba of a women succesfully. We learned a lot from this session and are excited […]
LSI: “It’s Women’s Health Awareness Month, and we’re highlighting a new women’s health company each day in May. Today we’re highlighting Choice – Female Proconception, led by CEO Peter Van De Graaf. Choice has developed small, implantable, wirelessly controlled valves as a contraceptive. Placed in a short, outpatient procedure, without the need for surgery, Choice […]
We proudly present you our first 1:1 prototype of Choice – inside this duct there is a working valve! The axles hold the valve and detent together in the duct and they will now be welded and shortened.
Our Co-Founder & CCA Leonie van de Kamer starring at the LSI Event in Barcelona last September! In the picture she is showing the world’s smallest endoscope developed together with OptaSensor GmbH to enhance placement of the Choice devices in the fallopian tubes and to prevent adverse events during placement.
What we did with the sheep & cow fallopian tubes, we repeated inside human fallopian tubes. Marlies Bongers & Bas Veersema, our gynaecologists from our Board of Advice went inside two just removed uterusses. We learned a lot, but unfortunately after the session our images were corrupted #$@!!. The ampulla, where fertilization takes place & […]
With our newly developed tools we are exploring where all of us began…Together with the UMC professors Bas Veersema (Gynaecology) & Peter Vos (Veterinary Medicine) we looked inside cow & sheep fallopian tubes (this is a sheep). Human fallopian tubes to follow soon.
We are happy to announce that we successfully passed our first ISO 13485 audit. This will lead to a ISO certification expected Q1 2023. This is an important step for Choice as this ISO certificate will help us grow within the medical device business (work together with suppliers and eventually customers) and will help the […]
Peter van de Graaf presented Choice to some 100 female students at Sohag University, followed by a lively discussion. Overall outcome was that most students considered Choice excellent contraception for themselves and Egypt in general, as we have found elsewhere. We must reach the poor, whose needs are highest because of their large families, leading […]
